Nelva Mata

2.2k citations

20 papers · 952 indexed · h-index 14

Impact in

Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Surgery top 5%
- Lipoproteins and Cardiovascular Health

Papers in

Surgery 17
- Lipoproteins and Cardiovascular Health 17
Endocrinology, Diabetes and Metabolism 6
- Diabetes, Cardiovascular Risks, and Lipoproteins 6

Co-authors: Rodrigo Alonso Pedro Mata Francisco Fuentes Ovidio Muñiz-Grijalvo José Luis Díaz-Díaz José López‐Miranda Lina Badimón Teresa Padró
Journals: Atherosclerosis (3 papers)Revista Española de Cardiología (English Edition) (2 papers)Expert Opinion on Drug Safety (1 paper)European Journal of Public Health (1 paper)International Journal of Cardiology (1 paper)
Partner nations: Spain Chile United States

In The Last Decade

Nelva Mata

20 papers receiving 934 citations

Peers

Countries citing papers authored by Nelva Mata

Since Specialization

Citations

This map shows the geographic impact of Nelva Mata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelva Mata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelva Mata more than expected).

Fields of papers citing papers by Nelva Mata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelva Mata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelva Mata. The network helps show where Nelva Mata may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nelva Mata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nelva Mata Line = papers co-authored together Nelva Mata links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study Public Health Nutrition ·幹夫羽澄, Rodrigo Alonso, Gracia M. Quintana‐Navarro, Francisco Fuentes, Nelva Mata, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Daniel Zambón, Francisco Arrieta, E. Sakai, Hira Iqbal, José R. Banegas, Pedro Mata	2019	16
2	Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry Atherosclerosis ·Mafalda Bourbon, Ana Catarina Alves, Rodrigo Alonso, Nelva Mata, Pedro Aguiar, Teresa Padró, Pedro Mata	2017	46
3	Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia Journal of clinical lipidology ·Pablo Lázaro, Leopoldo Pérez de Isla, Gerald F. Watts, Rodrigo Alonso, Richard Norman, Ovidio Muñiz-Grijalvo, Francisco Fuentes, Nelva Mata, José López‐Miranda, José Ramón González‐Juanatey, José Luis Díaz-Díaz, Antonio Javier Blasco, Pedro Mata	2017	80
4	Consecución de objetivos terapéuticos de colesterol LDL en niños y adolescentes con hipercolesterolemia familiar. Registro longitudinal SAFEHEART Revista Española de Cardiología ·Adriana Saltijeral, Leopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Francisco Fuentes, Nelva Mata, Raimundo de Andrés, Gonzalo Díaz-Soto, J.M. Pastor, 博明平岡, Daniel Zambón, Xavier Pintó, Lina Badimón, Pedro Mata	2017	29
5	Attainment of LDL Cholesterol Treatment Goals in Children and Adolescents With Familial Hypercholesterolemia. The SAFEHEART Follow-up Registry Revista Española de Cardiología (English Edition) ·Adriana Saltijeral, Leopoldo Pérez de Isla, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Francisco Fuentes, Nelva Mata, Raimundo de Andrés, Gonzalo Díaz-Soto, J.M. Pastor, 博明平岡, Daniel Zambón, Xavier Pintó, Lina Badimón, Pedro Mata	2016	28
6	Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study International Journal of Cardiology ·Francisco Fuentes, Juan F. Alcalá‐Díaz, Gerald F. Watts, Rodrigo Alonso, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Nelva Mata, Juan Francisco Sánchez Muñoz-Torrero, Ángel Brea, Jesús Galiana, Rosaura Figueras, Rocío Aguado, Mar Piedecausa, José María Cepeda, J. Y. Kim, Fernando Rodríguez-Cantalejo, José López‐Miranda, Pedro Mata	2015	30
7	Lipoprotein(a) Levels in Familial Hypercholesterolemia Journal of the American College of Cardiology ·Rodrigo Alonso, Eduardo Andrés‐León, Nelva Mata, Francisco Fuentes, Lina Badimón, José López‐Miranda, Teresa Padró, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, Marta Mauri, José M. Ordovás, Pedro Mata	2014	259
8	Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes Expert Review of Cardiovascular Therapy ·Rodrigo Alonso, Pedro Mata, Daniel Zambón, Nelva Mata, Francisco Fuentes	2013	30
9	Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities Atherosclerosis ·Paloma Caballero, Rodrigo Alonso, M. Madasamy, Nelva Mata, Leticia Fernández‐Friera, Luis Jesús Jiménez‐Borreguero, Lina Badimón, Pedro Mata	2012	40
10	Quality of life in a cohort of familial hypercholesterolemia patients from the south of Europe European Journal of Public Health ·Nelva Mata, P Collins James, José R. Banegas, Daniel Zambón, Ángel Brea, P. Mata	2012	17
11	Effect of a Smoking Ban and School-Based Prevention and Control Policies on Adolescent Smoking in Spain: A Multilevel Analysis Prevention Science ·Iñaki Galán, Lucía Díez‐Gañán, Ana Gandarillas, Nelva Mata, José L. Cantero, Maŕıa Durbán	2012	6
12	Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART) Lipids in Health and Disease ·Nelva Mata, Rodrigo Alonso, Lina Badimón, Teresa Padró, Francisco Fuentes, Ovidio Muñiz-Grijalvo, Francisco Pérez‐Jiménez, José López‐Miranda, José Luis Díaz-Díaz, Jose I. Vidal, Annalisa Barba, Mar Piedecausa, Juan Francisco Sánchez, Luis Irigoyen, Eliseo Güallar, José M. Ordovás, Pedro Mata	2011	98
13	Individual and Contextual Factors Associated to Smoking on School Premises Nicotine & Tobacco Research ·Iñaki Galán, Lucía Díez‐Gañán, Nelva Mata, Ana Gandarillas, José L. Cantero, Maŕıa Durbán	2011	7
14	Polymorphism at the TRIB1 gene modulates plasma lipid levels: Insight from the Spanish familial hypercholesterolemia cohort study Nutrition Metabolism and Cardiovascular Diseases ·Antonio García‐Ríos, Pablo Pérez‐Martínez, P. Mata, Francisco Fuentes, José López‐Miranda, Rodrigo Alonso, Javier Caballero‐Villarraso, Nelva Mata, Francisco Pérez‐Jiménez, José M. Ordovás	2010	10
15	Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform Clinical Biochemistry ·Rodrigo Alonso, Joep C. Defesche, Diego Tejedor, Sergio Castillo, Marianne Stef, Nelva Mata, Ana Isabel Tomás Fleta, Ceferino Martínez‐Faedo, Lluís Forga, Pedro Mata	2009	42
16	Cardiovascular disease in familial hypercholesterolaemia: Influence of low-density lipoprotein receptor mutation type and classic risk factors Atherosclerosis ·Rodrigo Alonso, Nelva Mata, Sergio Castillo, Francisco Fuentes, Pedro Luis Ruíz Sáenz, Ovidio Muñiz-Grijalvo, (unknown), R. Figueras, José Luis Díaz-Díaz, Ana Isabel Tomás Fleta, Marta Mauri, Mar Piedecausa, Luis Irigoyen, Rocío Aguado, P. Mata	2008	118
17	Cost-Effectiveness of Managing Familial Hypercholesterolemia Using Atorvastatin-Based Preventive Therapy Revista Española de Cardiología (English Edition) ·Rodrigo Alonso, Jaime Fernández de Bobadilla, Ignacio Méndez, Pablo Lázaro, Nelva Mata, Pedro Mata	2008	13
18	Coste-efectividad del manejo de la hipercolesterolemia familiar con estrategias de tratamiento preventivo basadas en atorvastatina Revista Española de Cardiología ·Rodrigo Alonso, Jaime Fernández de Bobadilla, Ignacio Méndez, Pablo Lázaro, Nelva Mata, Pedro Mata	2008	11
19	Impact of the "Tobacco control law" on exposure to environmental tobacco smoke in Spain BMC Public Health ·Iñaki Galán, Nelva Mata, Carmen Estrada, Lucía Díez‐Gañán, Luís Velázquez, Belén Zorrilla, Ana Gandarillas, L. Cury	2007	65
20	Benefits and risks assessment of simvastatin in familial hypercholesterolaemia Expert Opinion on Drug Safety ·Rodrigo Alonso, Nelva Mata, Pedro Mata	2005	7

About Nelva Mata

Nelva Mata is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Speech and Hearing, Economics and Econometrics and Pathology and Forensic Medicine, having authored 20 papers that have together received 952 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Genetic factors in colorectal cancer (3 papers), Pharmaceutical Economics and Policy (3 papers), Smoking Behavior and Cessation (3 papers), School Health and Nursing Education (2 papers) and Obesity, Physical Activity, Diet (2 papers). The work is most often cited by research in Cancer Research (280 citations), Surgery (786 citations), Endocrinology, Diabetes and Metabolism (294 citations), Cardiology and Cardiovascular Medicine (201 citations) and Economics and Econometrics (146 citations). Nelva Mata has collaborated with scholars based in Spain, Chile and United States. Frequent co-authors include Rodrigo Alonso, Pedro Mata, Francisco Fuentes, Ovidio Muñiz-Grijalvo, José Luis Díaz-Díaz, José López‐Miranda, Lina Badimón, Teresa Padró, Marta Mauri and José M. Ordovás. Their work appears in journals such as Atherosclerosis, Revista Española de Cardiología (English Edition), Expert Opinion on Drug Safety, European Journal of Public Health and International Journal of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact